Tirzepatide Research Supplier in Delhi, India
Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.
Aarise Healthcare supplies Tirzepatide (CAS: 2023788-19-2) to research institutions, universities, and laboratories in Delhi, India. Our Tirzepatide is supplied at 98%+ purity for dual GIP/GLP-1 incretin receptor research.
Tirzepatide Research Supply Specifications — Delhi
| Compound | Tirzepatide |
| CAS Number | 2023788-19-2 |
| Purity | 98%+ (HPLC verified) |
| Form | Lyophilised powder |
| Storage | -20°C, protected from light |
| MOQ | 5mg (research quantities) |
| Delivery to Delhi | 2-4 business days |
| Documentation | CoA, HPLC report, MS data |
Research Applications of Tirzepatide
Tirzepatide is used in dual GIP/GLP-1 incretin receptor research. Research institutions in Delhi use this compound for preclinical studies and laboratory investigations under appropriate research protocols.
Why Research Institutions in Delhi Source from Aarise Healthcare
- WHO-GMP certified manufacturing facility
- 98%+ purity with independent third-party CoA
- Temperature-controlled shipping to Delhi
- Dedicated research supply team
- Bulk quantities available for ongoing research programmes
- Fast 2-4 day delivery across India including Delhi
Related Peptides Available in Delhi
Semaglutide in Delhi | Retatrutide in Delhi | Liraglutide in Delhi | Mazdutide in Delhi
Tirzepatide Research Supply — Other Indian Cities
Tirzepatide in Mumbai | Tirzepatide in Hyderabad | Tirzepatide in Bangalore | Tirzepatide in Chennai
Request Tirzepatide for your Delhi research facility: Contact our research supply team with your institution details and quantity requirements. We respond within 24 hours with pricing and availability.
